Biography:
Zhou Xueyan, Ph.D., currently an Assistant Researcher and Postdoctoral Fellow at Aier Eye Hospital Group Co., Ltd. she earned Ph.D. from Nankai University, where she established a specialized research focus on anterior segment inflammatory disorders. Her current research is dedicated to advancing ocular drug delivery systems through the rational design of polymeric prodrug formulations. She have co-first-authored an SCI paper in the Journal of Controlled Release and have contributed to seven additional peer-reviewed SCI publications.
Title : Subconjunctival injection of microcrystalline prodrug of dexamethasone for long acting anti inflammation after phacoemulsification surgery